文献速递乳房整形与再造创面修复

放疗参数与围手术期并发症对乳房再造结局的影响

The Relationship of Radiation Therapy Parameters and Perioperative Morbidity and Toxicities on Breast Reconstruction Outcomes.
PubMed 文献 · Ann Plast Surg · 2026-02-02

结果显示放疗前并发症不延迟PMRT,严重皮炎不延迟置换,IMRT和质子治疗较3DCRT减少严重皮炎,bolus增加皮炎风险。

要点

  • 放疗前手术部位并发症不延迟PMRT启动(P=0.61)。
  • 严重皮炎不延迟扩张器-假体置换(P=0.63)。
  • IMRT和质子治疗较3DCRT减少严重皮炎,bolus增加皮炎风险。

核心结论

  • 在PMRT与再造同机构完成的整合诊疗环境中,放疗前并发症与PMRT延迟无关,放疗后并发症或急性毒性不改变假体置换进程。

主要发现

  • 多数(87.5%)接受双阶段再造。
  • 约四分之一乳房在PMRT前出现不良手术部位结局,PMRT后比例相似。
  • 放疗前手术部位结局未延迟PMRT(P=0.61),严重皮炎未延迟扩张器-假体置换(P=0.63)。
  • 严重皮炎在IMRT(P<0.01)和质子治疗(P<0.02)中较3DCRT更少,bolus使用增加皮炎风险(P<0.01)。
  • 胸肌前与胸肌下再造后严重包膜挛缩差异未达统计学显著性(P=0.30)。

临床怎么用

  • 放疗前手术部位并发症不应作为延迟PMRT的理由。
  • 严重皮炎不构成延迟扩张器-假体置换的依据。
  • 优先选择IMRT或质子治疗以减少严重皮炎,慎用bolus。
  • 需多学科协作规划与沟通以优化治疗与结局。

局限性

  • 单中心回顾性设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postmastectomy radiation therapy (PMRT) is a key component of breast cancer care, reducing locoregional recurrence in appropriately selected patients. Concurrently, use of mastectomy with implant-based breast reconstruction has expanded, heightening attention to how patient, surgical, and radiation factors interact. There is a knowledge gap in how reconstructive strategies and PMRT parameters jointly influence complications, toxicities, and treatment timing across the expander-implant continuum. OBJECTIVE: The aim of this study was to determine how reconstructive and radiation therapy (RT) parameters relate to surgical-site complications, delays in PMRT initiation, acute radiation toxicities, delays in expander-to-implant exchange, and capsular contracture. METHODS: This study examined a single-center retrospective cohort of women undergoing mastectomy with immediate tissue expander or direct-to-implant reconstruction and PMRT (2017-2022). Complications classified as postmastectomy pre-RT, intra-RT, and post-RT. Associations between clinical and radiation factors and complications, toxicities, and delays were estimated using generalized estimating equation logistic models. RESULTS: One hundred forty-six patients underwent 260 mastectomies, and 152 reconstructions received PMRT. The majority underwent dual-stage reconstruction (87.5%). Adverse surgical site outcomes occurred in approximately one-quarter of breasts before PMRT and in a similar proportion after PMRT. Neither pre-RT surgical site outcomes delayed PMRT ( P = 0.61) nor did severe dermatitis delay expander-to-implant exchange ( P = 0.63). Severe dermatitis was less frequent with intensity-modulated RT ( P < 0.01) and proton therapy ( P < 0.02) than with three-dimensional conformal RT, whereas bolus use increased the risk of dermatitis ( P < 0.01). Severe capsular contracture occurred less frequently after prepectoral versus submuscular reconstruction, but the difference did not reach statistical significance ( P = 0.30). CONCLUSIONS: In an integrated care setting where PMRT and reconstruction are performed in the same institution, pre-RT complications do not correlate with delaying PMRT, nor do post-RT complications or acute toxicities alter the implant exchange course. Complications were substantial during the pre-RT period, suggesting further opportunities for improvement. These findings emphasize the importance of multidisciplinary planning/communication to optimize patient treatment and outcomes.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Khan S, Olsen TC, Voytik M, et al. The Relationship of Radiation Therapy Parameters and Perioperative Morbidity and Toxicities on Breast Reconstruction Outcomes. Ann Plast Surg. 2026. PMID: 41628394. doi:10.1097/SAP.0000000000004647

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。